Eli Lilly and Co (LLY)
745.95
-4.82
(-0.64%)
USD |
NYSE |
Apr 18, 16:00
740.38
-5.57
(-0.75%)
Pre-Market: 06:27
Eli Lilly Shares Outstanding: 950.77M for Feb. 28, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 28, 2024 | 950.77M |
February 16, 2024 | 950.16M |
December 31, 2023 | 949.38M |
October 30, 2023 | 949.31M |
September 30, 2023 | 949.30M |
August 03, 2023 | 949.30M |
June 30, 2023 | 949.29M |
April 24, 2023 | 949.27M |
March 31, 2023 | 949.27M |
February 22, 2023 | 952.35M |
February 21, 2023 | 950.30M |
February 17, 2023 | 950.30M |
December 31, 2022 | 950.18M |
October 28, 2022 | 950.18M |
September 30, 2022 | 950.18M |
August 01, 2022 | 950.17M |
June 30, 2022 | 950.17M |
April 26, 2022 | 950.16M |
March 31, 2022 | 950.60M |
February 22, 2022 | 952.35M |
February 18, 2022 | 952.35M |
December 31, 2021 | 953.65M |
October 22, 2021 | 956.59M |
September 30, 2021 | 956.59M |
July 30, 2021 | 956.58M |
Date | Value |
---|---|
June 30, 2021 | 956.58M |
April 27, 2021 | 959.03M |
March 31, 2021 | 959.48M |
March 27, 2021 | 959.03M |
February 22, 2021 | 958.99M |
February 12, 2021 | 958.43M |
December 31, 2020 | 956.59M |
October 26, 2020 | 956.58M |
September 30, 2020 | 956.49M |
July 27, 2020 | 956.47M |
June 30, 2020 | 956.47M |
April 27, 2020 | 956.45M |
March 31, 2020 | 956.93M |
March 09, 2020 | 957.04M |
February 13, 2020 | 956.38M |
December 31, 2019 | 957.53M |
October 21, 2019 | 960.13M |
September 30, 2019 | 960.05M |
July 29, 2019 | 965.43M |
June 30, 2019 | 965.96M |
April 29, 2019 | 970.83M |
March 31, 2019 | 970.82M |
March 11, 2019 | 970.82M |
February 26, 2019 | 1.036B |
February 13, 2019 | 1.035B |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
949.27M
Minimum
Mar 31 2023
970.83M
Maximum
Apr 29 2019
954.77M
Average
956.42M
Median
Shares Outstanding Benchmarks
Amgen Inc | 535.92M |
Madrigal Pharmaceuticals Inc | 19.90M |
Vertex Pharmaceuticals Inc | 258.31M |
Viking Therapeutics Inc | 100.49M |
Moderna Inc | 382.88M |